96 studies found for:    Open Studies | "Anemia, Aplastic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anemia, Aplastic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
2 Recruiting Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Very Severe Aplastic Anemia;   Moderate Aplastic Anemia
Intervention: Drug: Eltrombopag
3 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath )
4 Recruiting Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Condition: Anemia, Aplastic
Intervention: Drug: Cyclophosphamide,Campath IH and TBI
5 Unknown  Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Procedure: Ex Vivo Immunotherapy;   Drug: Ex vivo immunotherapy
6 Recruiting Fludarabine-based Conditioning for Severe Aplastic Anemia
Condition: Anemia, Aplastic
Intervention: Drug: Cyclophosphamide
7 Unknown  Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: Sirolimus;   Drug: Cyclosporine
8 Recruiting A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: AMG531
9 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
10 Recruiting Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cy-ATG;   Drug: Flu-ATG
11 Recruiting Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia
Condition: Acquired Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Radiation: Total body irradiation;   Procedure: CD3-depleted hematopoietic cell transplantation
12 Unknown  Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)
Condition: Aplastic Anemia
Intervention: Other: Cyclophosphosphamide, TBI
13 Recruiting Cord Blood Transplantation in Severe Aplastic Anemia
Conditions: Hereditary Diseases;   Acquired Aplastic Anemia;   Relapse;   Absence of an HLA Identical Donor
Intervention: Procedure: Cord Blood Transplantation
14 Not yet recruiting Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Condition: Aplastic Anemia
Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A);   Drug: Immunosupressive therapy (Cyclosporine A)
15 Recruiting Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS);   Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood;   Other: Haploidentical Stem Cells;   Device: Miltenvi CliniMACs CD34 Reagent System
16 Unknown  Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
Condition: Aplastic Anemia and Other Marrow Failure Syndrome
Intervention: Other: Database
17 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Conditions: Severe Aplastic Anemia;   MDS (Myelodysplastic Syndrome)
Interventions: Device: Miltenyi CD34 Reagent System;   Other: Donor derived G-CSF mobilized PBC
18 Recruiting Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Anemia;   Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Horse Anti-Thymocyte Globulin (ATG);   Drug: Cyclosporine A (CSA)
19 Unknown  Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)
Condition: Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Thymoglobulin
20 Unknown  Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.
Condition: Aplastic Anemia
Intervention: Biological: bone marrow derived mesenchymal stem cells

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years